Expression pattern of tumor endothelial marker 8 protein in gallbladder carcinomas

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 2, 2011, Pages 507-512

  Maurya, Sanjeev Kumar ^a   Tewari, Mallika ^a   Kumar, Mohan ^a   Thakur, Mahendra Kumar ^a   Shukla, Hari Shanker ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Angiogenesis; Endothelial marker; Gallbladder carcinoma; New vasculature

Indexed keywords

EID: 79958803681     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Abrami L, Leppla SH, van der Goot FG (2006). Receptor palmitoylation and ubiquitination regulate anthrax toxin endocytosis. J Cell Biol, 172, 309-20.
2. Bonuccelli G, Sotgia F, Frank PG, et al (2005). ATR/TEM8 is highly expressed in epithelial cells lining Bacillus anthracis' three sites of entry: implications for the pathogenesis of anthrax infection. Am J Physiol Cell Physiol, 288, 1402-10.
3. Bradley KA, Mogridge J, Mourez M (2001). Identification of the cellular receptor for anthrax toxin. Nature, 414, 225-9.
4. Carson-Walter EB, Watkins DN, Nanda A, et al (2001). Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res, 61, 6649-55.
5. Darabos N, Stare R (2004). Gallbladder cancer: laparoscopic and classic cholecystectomy. Surg Endosc, 18, 144-7.
6. Davies G, Cunnick GH, Mansel RE, et al (2004). Levels of expression of endothelial markers specific to tumourassociated endothelial cells and their correlation with prognosis in patients with breast cancer. Clin Exp Metastasis, 21, 31-7.
7. Duan HF, Hu XW, Chen JL, et al (2007). Antitumour activities of TEM8-Fc: an engineered antibody-like molecule targeting tumour endothelial marker 8. J Natl Cancer Inst, 99, 1551-5.
8. Grant DS, Kleinman HK (1997). Regulation of capillary formation by laminin and other components of the extracellular matrix. EXS, 79, 317-33.
9. Hotchkiss KA, Basile CM, Spring SC, et al (2005). TEM8 expression stimulates endothelial cell adhesion and migration by regulating cell-matrix interactions on collagen. Exp Cell Res, 305, 133-44.
10. HS Shukla (2006). Gallbladder cancer. J Surg Oncol, 93, 604-6.
11. Kalluri R (2003). Angiogenesis: basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer, 3, 422-33.
12. Kerbel R, Folkman J (2002). Clinical translation of angiogenesis inhibitors. Nat Rev Cancer, 2, 727-39.
13. Lazcano-Ponce EC, Miquel JF, Muñoz N, et al (2001). Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin, 51, 349-64.
14. Liu S, Leppla SH (2003). Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization. J Biol Chem, 278, 5227-34.
15. Marneros AG, Olsen BR (2001). The role of collagen-derived proteolytic fragments in angiogenesis. Matrix Biol, 20, 337-45.
16. Maurya SK, Tewari M, Thakur MK, et al (2009). Stage dependent expression of MUC1 gallbladder carcinoma. J Cancer Res Exp Oncol, 1, 1-7.
17. Maurya SK, Tewari M, Shukla SH, et al (2010). Genetic aberration in gallbladder carcinoma. Surg Oncol, Sep 28, doi:10.1016/j.physletb.2003.10.071
18. Mooney D, Langer R, Ingber D (1995). Cytoskeletal filament assembly and the control of cell spreading and function by extracellular matrix. J Cell Sci, 108, 2311-20.
19. Nanda A, St Croix B (2004). Tumor endothelial markers: new targets for cancer therapy. Curr Opin Oncol, 16, 44-9.
20. Ramey JD, Villareal VA, Ng C, et al (2010). Anthrax toxin receptor 1/tumor endothelial marker 8: mutation of conserved inserted domain residues overrides cytosolic control of protective antigen binding. Biochemistry. 31, 49, 7403-10.
21. Scobie HM, Rainey GJ, Bradley KA, et al (2003). Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc Natl Acad Sci U S A, 100, 5170-4.
22. Shukla HS, Awasthi K, Naithani YP, et al (1981). A clinicopathological study of carcinoma of the gall bladder. Indian J Cancer, 18, 198-201.
23. St Croix B, Rago C, Velculescu V, et al (2000). Genes expressed in human tumor endothelium. Science, 289, 1197-202.
24. Thijssen VL, Postel R, Brandwijk RJ, et al (2006). Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci U S A, 103, 15975-80.
25. Venanzi FM, Petrini M, Fiammenghi L, et al (2010). Tumor endothelial marker 8 expression levels in dendritic cell-based cancer vaccines are related to clinical outcome. Cancer Immunol Immunother, 59, 27-34.
26. Werner E, Kowalczyk AP, Faundez V (2006). Anthrax Toxin Receptor 1/Tumor Endothelium Marker 8 Mediates Cell Spreading by Coupling Extracellular Ligands to the Actin Cytoskeleton. J Biol Chem, 281, 23227-36.
27. Yang MY, Chaudhary A, Seaman S, et al (2010). The cell surface structure of tumor endothelial marker 8 (TEM8) is regulated by the actin cytoskeleton. Biochim Biophys Acta, doi:10.1016/j.physletb.2003.10.071.